Thank you for joining us today for TOMI's Environmental Solutions Investor Update Conference Call. On today's call is TOMI's CEO and Chairman of the Board, Dr. Halden Shane, who will provide an overview of recent business highlights for the most recent quarter. TOMI's CFO, Nick Jennings will follow-up and discuss critical financial benchmarks before addressing any questions you may have.A telephone replay of today's call will be available through May 25, 2020, the details of which are included in the Company's press release of May 12, 2020. A webcast replay will also be available at TOMI's website, www.tomimist.com. Please note that information contained within this call is relevant only to the day of which it was recorded, May 18, 2020, and you are therefore advised the time sensitive information may no longer be accurate at the time of any replay. Certain written or oral statements made by management of TOMI may constitute forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995.Forward-looking statements are identified by such words and phrases as we expect, expected to, estimates, estimated, current outlook, we look forward to, would equate to, projects, projections, projected to be, anticipates, anticipated, we believe, could be, and other similar phrases. All statements addressing operating performance, events, or developments that the Company expects or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this conference call is based upon the facts and circumstances known at this time. The Company undertakes no obligation to update these forward-looking statements after the date of this call.I will now proceed to get the call to TOMI's CEO and Chairman of the Board, Dr. Halden Shane.

Thank you for taking the time away from your schedule to join us this afternoon. This is a unique experience given an earnings call with the mask. But first, I would like to give you my opening. Some of you are quarantined in place for good reasons, most are sheltering-in-place for other reasons. The Director of Los Angeles Department of Public Health has ordered $12.5 million Los Angelina to shelter-in-place until August. That's beyond my scientific comprehension.I guess I would feel better if she was a real doctor, an epidemiologist or infectious disease specialist, but a PhD in Social Welfare and a Bachelor of Arts and Community Studies. The salary of over $400,000, I just don't get it. Most of us are mature enough to follow real science guidelines like the 47 or 48 other states using mask, social distancing, frequent washing of hands, et cetera. Well, that is my opening.Now to the good news. Today, we will be reviewing TOMI's Environmental Solutions, Inc.'s first quarter 2020 financial results, along with noteworthy recent developments for the beginning of our fiscal year-to-date. This review will address the business update on all sectors and divisions, relevant financial and brief overview of ongoing developments and efforts here at TOMI and its SteraMist brand.Following my opening statements, our Chief Financial Officer, Nick Jennings will lead us into our first quarter 2020 financial results. After years of slow but steady growth, 2020 has been groundbreaking for TOMI's SteraMist throughout a wealth of areas in the wake of recent global events, recording breaking gross profits as well as improved operating results overshadow previous year's performance.As always our revenues attributed to a variety of sources such as recurring BIT solution orders, SteraMist equipment purchases and the growth of our TOMI Service Network, TSN and the added SteraMist…

Thank you, Dr. Shane. I'll provide a brief overview of our financial results for the first quarter of 2020 compared to the prior year period. For the three months ended March 31, 2020 compared to March 31, 2019, total net revenue was $7,053,000 compared to $1,253,000, representing an increase of $5,800,000, or 463%.The increase in revenue was attributable to increase global demand for disinfection in infectious disease control products in response to the SARS CoV-2 coronavirus global pandemic. In the first quarter, we saw significant demand for our product from hospital-healthcare and TSN as a result of the pandemic. Entering into Q1, we were fortunate to have sufficient inventory levels on hand to meet customer demand.To provide a further breakdown of revenue, SteraMist product-based revenue was $6,638,000 and $1,029,000, representing an increase of $5,609,000 or 545%. Service-based revenue was approximately $415,000 and $224,000, representing a year-over-year increase of 85%. Domestic revenue was $3,569,000 and $1,136,000, an increase of $2,433,000, or 214%.International revenue was approximately $3,484,000 and $117,000, representing an increase of $3,367,000 or 2,878%. Gross margins were 63.6% compared to 60.6%. The higher gross profit was attributable to product mix and sales. Income from operations was $2,659,000, compared to a loss from operations of $868,000, representing an increase of $3,527,000. The increase in our operating income relates to higher revenue and gross profit offset by increased operating costs.Net income was $2,619,000, or $0.02 on a per share basis compared to a net loss of $935,000, or $0.01 on a per share basis, representing an increase of $3,554,000. EBITDA was $2,831,000 compared to an adjusted net loss of $691,000. For additional information on calculation of EBITDA and the reconciliation to our GAAP net income, please refer to our press release, dated May 18 for additional details.Cash provided from operations was $3,316,000, compared to cash used in operations of $649,000.Next, I'd like to go through some of the key items on our balance sheet. As of March 31, 2020 and December 31, 2019, cash and cash equivalents of approximately $3,756,000 and $897,000, representing an increase of $2,859,000. Working capital was $6,365,000 and negative $1,266,000, representing an increase of $7,631,000. Conversion of $4.5 million in convertible notes into 8,333,000 common shares. Shareholder equity was $8,324,000 and $890,000, representing an increase of $7,434,000.Our cash and liquidity position improved in the first quarter due to higher revenue and gross profit and the restructuring of customer payment terms where we began requiring deposits and prepayments on our equipment and solution orders. This was offset by the repayment of convertible notes in cash of $500,000 and vendor deposits of approximately $1,267,000. Our Q1 income and the conversion of the convertible notes provided a nice boost to our working capital and shareholder equity.Looking forward, we are excited to add more employees, expand production capacity, and continue our fight to make the world a safer place.Now I'll turn the call back over to Dr. Shane.

Thank you, Nick. Not that I have a crystal ball, but I think when we look back into 2020 we'll see the infectious disease protocols have changed forever over this COVID-19 pandemic. Many of us who and who did not know what virtual meant before over the last three months, I'm sure I truly understand it as it has become part of our daily lives as a result of COVID-19 pandemic.I think the people that said never to virtual will now understand that the world has been transformed overnight. For example, the delivery of healthcare has been changed forever. Already as this pandemic was a turning point in the house, our citizens interact with healthcare systems i.e. virtual doctors. Transformation has also occurred in the cleaning industry. Infectious disease protocols in the world will never go back to the old way of doing things. Manual cleaning for the most part will be a method of the past except for those growth visual materials, which, of course, will needs to be removed. Mechanical clean is here to stay forever.I remember during the last Ebola outbreak, SteraMist played a significant role in West Africa. We won a large grant from USA, CDC and Office of the President. After this infected in many hospitals and facilities in West Africa, we came home to a new norm of what should have been a new norm, pandemic preparedness.Fortunately for America, Africa did a good job, quickly was able to contain Ebola outbreak to West Africa. Thank God for that because of the country, we were not prepared. Imagine what the world would look like with a 90-plus percentage fatality rate. Post Ebola, there was to be significant dollars available which were to be put aside for preparedness kits. Many hospitals did purchase our SteraMist Surface…

And I thank you all for listening today. The call is now terminated.

Ladies and gentlemen, that will conclude today's conference. We thank you for your participation. You may disconnect at this time and have a great day.